⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1066055 | 0.93 | — | — | |
| SCHEMBL9487092 | 0.89 | CA12 (0.47) | — | |
| SCHEMBL1230675 | 0.87 | CYP1A2 (0.38) | — | |
| SCHEMBL10838909 | 0.86 | CYP1A2 (0.42) | — | |
| SCHEMBL1064909 | 0.86 | CYP1A2 (0.42) | — | |
| SCHEMBL3483661 | 0.84 | — | — | |
| SCHEMBL5094912 | 0.83 | CYP1A2 (0.40) | — | |
| SCHEMBL8763515 | 0.81 | LMNA (0.38) | — | |
| SCHEMBL687370 | 0.80 | — | — | |
| SCHEMBL8764297 | 0.79 | CYP1A2 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080014288-A1 | Zinc-containing treatments for hyperphosphatemia | GENZYME CORPORATION | 2008-01-17 | — | — | US | disclosed |
| US-20060002888-A1 | Polyionenes for treating infections associated with cystic fibrosis | GENZYME CORPORATION (US) | 2006-01-05 | — | — | US | disclosed |
| US-20060002889-A1 | Polyionene polymers with hydrolyzable linkages | GENZYME CORPORATION (US) | 2006-01-05 | — | — | US | disclosed |
| US-20060002887-A1 | Ionene oligomers and polymers | GENZYME CORPORATION (US) | 2006-01-05 | — | — | US | disclosed |
| WO-2004085448-A2 | UNSATURATED PHOSPHINYL-PHOSPHONATE PHOSPHATE TRANSPORT INHIBITORS | GENZYME CORPORATION (US) | 2004-10-07 | — | — | WO | disclosed |
| WO-2004046109-A2 | IONENE OLIGOMERS AND POLYMERS | GENZYME CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004045629-A1 | POLYIONENES FOR TREATING INFECTIONS ASSOCIATED WITH CYSTIC FIBROSIS | GENZYME CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004046223-A2 | POLYIONENE POLYMERS WITH HYDROLYZABLE LINKAGES | GENZYME CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004044219-A2 | XANTHENE COMPOUNDS FOR CANCER CHEMOTHERAPY | MERCURY THERAPEUTICS, INC. (US) | 2004-05-27 | — | — | WO | disclosed |
| US-20030021761-A1 | Ionene polymers and their use in treating mucositis | GELTEX PHARMACEUTICALS, INC. (US) | 2003-01-30 | — | — | US | disclosed |
| WO-2002056895-A2 | IONENE POLYMERS AND THEIR USE IN TREATING MUCOSITIS | GENZYME CORPORATION (US) | 2002-07-25 | — | — | WO | disclosed |